A bioinformatic analysis identifies circadian expression of splicing factors and time-dependent alternative splicing events in the HD-MY-Z cell line by Genov, Nikolai et al.
1Scientific RepoRtS |         (2019) 9:11062  | https://doi.org/10.1038/s41598-019-47343-w
www.nature.com/scientificreports
A bioinformatic analysis identifies 
circadian expression of splicing 
factors and time-dependent 
alternative splicing events in the 
HD-MY-Z cell line
nikolai Genov1,2, Alireza Basti1,2, Mónica Abreu  1,2, Rosario Astaburuaga1,2 &  
Angela Relógio  1,2
the circadian clock regulates key cellular processes and its dysregulation is associated to several 
pathologies including cancer. Although the transcriptional regulation of gene expression by the 
clock machinery is well described, the role of the clock in the regulation of post-transcriptional 
processes, including splicing, remains poorly understood. In the present work, we investigated the 
putative interplay between the circadian clock and splicing in a cancer context. For this, we applied 
a computational pipeline to identify oscillating genes and alternatively spliced transcripts in time-
course high-throughput data sets from normal cells and tissues, and cancer cell lines. We investigated 
the temporal phenotype of clock-controlled genes and splicing factors, and evaluated their impact in 
alternative splice patterns in the Hodgkin Lymphoma cell line HD-MY-Z. our data points to a connection 
between clock-controlled genes and splicing factors, which correlates with temporal alternative splicing 
in several genes in the HD-MY-Z cell line. these include the genes DPYD, SS18, VIPR1 and IRF4, involved 
in metabolism, cell cycle, apoptosis and proliferation. Our results highlight a role for the clock as a 
temporal regulator of alternative splicing, which may impact malignancy in this cellular model.
Pre-mRNA splicing is a fundamental biological process through which the introns of a nascent RNA are removed 
and exons are merged to form a mature RNA that is then translated into a protein. Splicing is catalysed by a 
large ribonucleoprotein (RNP) complex – the spliceosome1. This macromolecular complex is guided by cis-acting 
sequences on the pre-mRNA (splice sites, exonic and intronic splicing enhancers and silencers) and interacts 
with trans-acting elements (splicing factors - SF) to excise the pre-mRNA at the intron/exon junctions (so-called 
splice junctions). Notably, up to 94% of human genes undergo differential splicing and thus exhibit various 
alternative-spliced isoforms giving rise to a variety of proteins from the same pre-mRNA2. Hence, via alternative 
splicing (AS) different proteins are generated, resulting in a greater variety of cellular functions and pathways. AS 
has been reported to be involved in the specification of several features of protein function including their cellular 
localization, enzymatic properties and their interaction with ligands, as well as their role in gene expression reg-
ulation and histone modifications3.
Like many cellular processes, AS is differentially regulated during cellular growth and tissue development4. 
This plasticity is also of advantage during tumorigenesis as it enables cancer cells to produce proteins that suit 
their proliferative and metastatic needs. By using AS, cancer cells benefit from isoforms specific to particular 
stages of oncogenesis and disease development5–7. The dysregulation of AS appears to affect almost all aspects of 
tumour biology, including cell cycle control, metastasis, metabolism, invasion and angiogenesis5,8. Furthermore, 
published work has revealed cancer-specific altered splicing patterns in various cancer types (e.g. Hodgkin 
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lymphoma, colon cancer and lung cancer) and identified several splicing factors that act as oncoproteins and 
contribute to tumour initiation (e.g. hnRNP E1, SF2/ASF and SRSF6)9–16. In particular, the analysis of AS using 
microarray data revealed stage–specific AS patterns between cell lines derived from Hodgkin lymphoma (HL) 
tumours at stage IIIb (HD-MY-Z) and IV (HDML-2) that are distinguishable from a non-tumour B lympho-
blastoid cell line (LCL-HO) and from HL tumours of different stages11. Additionally, several splicing factors (e.g. 
hnRNP E1, U2AF65 and NOVA-1/2) are differentially expressed between HL cell lines and the B lymphoblastoid 
cell line LCL-HO. Accordingly, HL tumours from the same stage (HDML-2 and L-540, stage IV) show greater 
similarity in their splicing pattern (70%) when compared to HL stage III cell line (~55%)11.
Recent studies in mice showed a correlation between certain SF and the functionality of the clock machin-
ery17,18. Furthermore, specific RNA-binding proteins involved in AS (e.g. LARK, hnRNP Q, CIRP, 4E-Bp1) were 
reported to regulate the expression of core-clock components in terms of mRNA localization, stability, and trans-
lation19–22. Conversely, several co-transcriptional and post-transcriptional processes have been reported to be 
regulated in a circadian manner in mammals, including AS, polyadenylation, mRNA stability and transport23,24. 
These findings point to a bidirectional interplay between the components and mechanisms of splicing and the 
circadian clock. Numerous studies have illustrated the role of the mammalian circadian clock in key cellular path-
ways and functions (such as the cell cycle25, metabolism26 and the immune system27) and revealed a prominent 
role of clock disruption in tumorigenesis26,28,29. Despite the increasing relevance of AS in cancer onset and pro-
gression, the role of the circadian clock as an intermediary component in this process remains unknown, and only 
a few studies have investigated the circadian expression phenotype of splicing factors and their impact in AS18,23,30.
In this study, we analysed time-course microarray data sets to identify oscillating genes, and to investigate the 
expression of SF in different tissue types and cell lines from mouse and human cell lines. In addition, we used a 
recently published31 time-course data set for the HD-MY-Z cell line, for which stage-specific patterns of AS have 
previously been described11, as a cellular model system to investigate a possible correlation between the circadian 
clock and the splicing machinery. We found connections between the core-clock and clock-controlled genes and 
a pre-defined set of SF, by means of protein-protein interaction networks. Additionally, we analysed the extent of 
AS events in the HD-MY-Z cell line in a time-dependant manner and identified several genes, including DPYD 
(dihydropyrimidine dehydrogenase), IRF4 (interferon regulatory factor 4), POP4 (POP4 homolog, ribonuclease 
P/MRP subunit), SS18 (nBAF chromatin remodelling complex subunit), MAGOH (mago homolog, exon junc-
tion complex subunit) and VIPR1 (vasoactive intestinal peptide receptor 1), involved in the cell cycle, apoptosis, 
drug metabolism and RNA processing and splicing that show expression patterns resulting from a temporal AS. 
Our results emphasize the existence of a putative circadian regulation of SF that subsequently may impact on AS 
decisions potentially relevant in cancer onset and or progression.
Results
A network analysis reveals distinct interacting clusters among splicing factors involved in vari-
ous cellular pathways. To analyse the putative regulation of RNA splicing processes via the circadian clock 
we started by compiling a comprehensive list of splicing factors (SF). The SF-list merges data from different 
sources: the SpliceAid232 database, the TIN R package33 and from a previous publication by Relógio et al.11. This 
resulted in a list of 341 splicing factors (Supp. Table S1), which we used for further analysis as input to an inte-
grated pipeline as indicated in the Fig. 1a.
The pipeline involves the analysis of time-course high-throughput data obtained with the splicing-sensitive 
Affymetrix HTA-2.0 arrays, a bioinformatic analysis by protein-protein interaction networks, the Reactome path-
way enrichment of genes for which changes in alternative splicing behaviour are detected. We also include an 
analysis for enrichment of transcription factors binding sites in the promoter regions of the splicing factors, and 
the computational evaluation of alternative splicing events, as well as their visualization. First, we used the SF 
list to explore the correlations among its elements, by creating a network of SF based on protein-protein interac-
tion data from the IntAct database. The data retrieved from the database forms one large connected component 
containing a total of 237 nodes and 898 edges. A clustering based on the interactions between the nodes using a 
community-clustering algorithm (GLay) resulted in nine clusters (Supp. Fig. S1 and Supp. Table S2). We further 
analysed the functional relevance of the clusters by performing a comparative enrichment analysis for Reactome 
pathways (Supp. Table S3), which yielded 18 pathway clusters (p < 0.05) (Fig. 1b). Splicing related terms are 
found in all clusters (e.g. mRNA splicing, Processing of Capped Intron-Containing Pre-mRNA), which justi-
fies our selection of SFs and strengthens their specificity. The enrichment also highlights additional functional 
diversity among the clusters of SF. Cluster 8 shows a strong correlation to RNA Polymerase II (p = 1.018E-19) 
and nonsense-mediated decay (NMD) appears enriched for two of the clusters (Cluster 9 and 3, p = 1.626E-
11 and 2.371E-02 respectively), a process which is involved in the degradation of aberrant mRNA isoforms. 
Additionally, FGFR2 (fibroblast growth factor receptor 2) signalling or AS of FGFR2 is enriched in clusters 4, 
8 and 9. FGFR2 pathway is known for its role in cancer. It cross-talks (via activation or inhibition) with various 
signalling pathways, including WNT, Notch and Hedgehog involved in tissue development and cellular prolif-
eration34. Altogether, our enrichment analysis points to the involvement of the selected SF in diverse cellular 
functions beyond splicing or splicing related terms.
oscillations in elements of the clock network correlate with oscillations in splicing factors in 
healthy and cancer samples. To investigate in more detail the existence of a putative interplay between 
the circadian clock and the SF, we performed an analysis of the interactions between elements of the predefined 
network of SF and elements of the network of circadian regulated genes (NCRG) previously published by our 
group35. For this network analysis, we used the data from the IntAct database (snapshot from 2015 present in iRe-
fIndex36). We identified 162 direct interactions based on the IRefIndex data (snapshot from 2015) between the SF 
and the NCRG sets, while a comparison of 100 randomly generated networks produced 34.7 ± 25.7 (mean ± SD) 
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interactions between the SF set and gene sets of the same size as the NCRG. Finally, we produced a detailed net-
work using the data retrieved from the current version of IntAct reduced to interacting nodes for the SF and the 
NCRG sets with Cytoscape (Supp. Fig. S2). The network contains 130 NCRG and 251 SF elements, in a total of 
186 connections (edges) between both sets. Additionally, 177 edges exist within the NCRG and 873 edges within 
the SF elements. In average each SF is connected to 0.74 NCRG elements and each NCRG element has in average 
1.43 connected SF. The elements with the highest degree of connections are CSNK2A1, MATR3 and WDR5 for 
the NCRG and SRPK2, EIF4A3 and RNPS1 for the SF sets. CSNK2A1 (Casein kinase II subunit alpha) is involved 
in numerous cellular processes, such as cell cycle control and apoptosis37. Additionally, CSNK2A1 plays an impor-
tant role in the circadian clock function by phosphorylating ARNTL (BMAL1) and thus controlling CLOCK 
nuclear entry38. MATR3 (Matrin-3) is a RNA binding protein involved in micro RNA regulation39 and activation 
Figure 1. The splicing factors form a tightly interconnected network with additional non-splicing 
functionalities. (a) Pipeline of the analysis approach for the detection of differential splicing. The original 
sources of data such as databases and publications are coloured in purple. The steps required for the creation 
of protein-protein interaction networks are coloured in blue. The array analysis steps are coloured in green. 
The resulting differential splicing is coloured in red. (b) The resulting nine clusters were investigated for the 
enrichment of Reactome pathways (p-values are indicated).
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of innate immune response40. WDR5 (WD repeat-containing protein 5) contributes to histone modification and 
(mainly of histone H3) and is therefore involved in epigenetic transcriptional activation41. From the set of SF ele-
ments, SRPK2 (SRSF protein kinase 2) is involved in the phosphorylation of SR splicing factors and in the process 
of spliceosome assembly and thus in the regulation of splicing42. EIF4A3 (Eukaryotic initiation factor 4A-III) is 
an ATP-dependant RNA helicase, which belongs to the spliceosome complex and is involved in pre-mRNA splic-
ing43,44. RNPS1 (RNA-binding protein with serine-rich domain 1) is part of pre-splicing multiprotein RNP com-
plex involved in RNA splicing45. Additionally, RNPS1 mediates NMD via interacting with the UPF complex46.
The high number of interactions between the NCRG and the SF, as compared to the average of the random 
sets, led us to investigate the existence of an enrichment of transcription factors (TF) binding sites, within the pro-
moter regions of SF elements, as defined in the HOCOMOCO v1047 database. We searched for TF binding sites 
of clock genes in the promoter regions of the SF, defined as the 2kbp upstream region, which yielded 231 enriched 
transcription factor binding site motifs mapped to 184 unique genes (Supp. Table S4). The total top scoring TFs 
are depicted in Fig. 2a. Our analysis identified central clock genes (CLOCK, p = 2.60E-25; ARNTL (BMAL1), 
p = 8.77E-4), as well as clock-related genes (ARNT2 - Aryl Hydrocarbon Receptor Nuclear Translocator 2, 
p = 1.09E-34) (Fig. 2b) to significantly bind to the promoter regions of the SFs as part of the total 184 detected 
unique TFs. We identified a total of 8 NCRG elements with enriched binding sites in the promoter regions of the 
splicing factors (AHR, ATF2, CLOCK, SMAD4, TEF, IRF7, SP1, ARNTL). AHR (aryl hydrocarbon receptor) is 
a Ligand-activated transcriptional activator involved in the cell cycle48. It also regulates the circadian clock by 
inhibiting the circadian expression of PER1 via repressing the CLOCK-ARNTL (BMAL1) heterodimer medi-
ated transcriptional activation of PER149. ATF2 (cyclic AMP-dependent transcription factor ATF-2) regulates the 
Figure 2. A bi-directional interplay between the splicing factors and the NCRG is achieved through direct 
protein-protein interactions and transcriptional regulation. (a) We detected 231 enriched motifs for binding 
sites with the MEME Suite AME tool for 184 unique transcription factors from the HOCOMOCOv10 database. 
The motifs and adjusted p-values for the top 5 scoring TFs are shown. (b) The promotor region of SF contains 
significantly (ARNTL p = 8.77E-04, ARNT2 p = 1.09E-34, CLOCK p = 2.60E-25) enriched transcription factor 
binding sites for several core-clock and clock-related genes. (c) Enrichment of Reactome pathways for the 
TFs with enriched binding sites in the promoter regions of the SF. The gene ratio denotes the ratio between 
the number of the genes associated with the term and the total number of genes associated with the term in 
the pathway. (d) Oscillations of the NCRG and splicing factors in Hodgkin Lymphoma (HD-MY-Z). The total 
number of genes for the NCRG and the SF is derived after mapping to human Entrez Gene IDs.
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transcriptional activation of various genes including those involved in cell growth and DNA damage response 
(e.g. ATM, Chk1 and Chk2)50. TEF (thyrotroph embryonic factor) is a transcription factor as well, which binds 
to a minimal DNA-binding sequence. IRF7 (interferon regulatory factor 7) is a transcriptional regulator of type 
I interferon (IFN)-dependent immune responses, which plays a critical role in the innate immune response. It 
regulates the transcription of type I IFN genes (IFN-alpha and IFN-beta) and IFN-stimulated genes (ISG)51. SP1 
(transcription factor Sp1) regulates the expression of a large number of genes involved in a variety of processes 
such as cell growth, apoptosis, differentiation and immune responses52–55. Additionally, SP1 was reported to pos-
itively regulate the transcription of the core-clock component ARNTL (BMAL1)56. This reinforces our initial 
hypothesis regarding an interplay between the circadian clock and the circadian regulation of the expression of 
splicing factors. The TF with lowest p-value detected for the promoter regions of the SF was EGR1 (Early Growth 
Response 1) (adjusted BH p = 6.69E-64) involved in the regulation of differentiation. EGR1 was shown to be 
activated by the CLOCK/BMAL1 heterodimer (via E-box elements) in mouse and regulates the transcription of 
several core-clock genes, including Bmal1, Per1, Per2 and Nr1d1 and Nr1d257. Interestingly, a pathway enrich-
ment analysis of the identified TFs with enriched binding site motifs reveals that the circadian clock pathway is 
highly enriched (adjusted BH p = 8.9767E-03), which underlines the connection of the TFs to the circadian clock 
(Fig. 2c, Supp. Table S5).
To further explore the regulation of splicing via the circadian clock, we investigated the expression phenotype 
of the circadian clock and SF elements in six high-throughput time-course datasets for human cell lines and 
mouse cells and tissues (all data sets are available from public repositories and their accession numbers provided 
in Materials and Methods).
The datasets consist of mouse macrophages (Supp. Fig. S3, GSE25585), mouse NIH3T3 fibroblasts (Supp. 
Fig. S3, GSE11922), mouse pituitary gland58 (Supp. Fig. S3) and mouse liver (Supp. Fig. S3, GSE11923), the can-
cer cell lines U2OS (human osteosarcoma, time course data set58, GSE13949, Fig. 2d) and HD-MY-Z (human 
Hodgkin Lymphoma cell line, time course data set27, ArrayExpress E-MTAB-6400, Supp. Fig. S4). The expres-
sion patterns of the circadian clock (represented by the NCRG) and SF elements in these high-throughput 
time-course datasets show a strong similarity between the two sets for all cell lines/tissues (Supp. Figs S3 and S4). 
This similarity is also apparent in the time-course high-throughput expression dataset for the human Hodgkin 
Lymphoma cell lines HD-MY-Z produced by our group (Fig. 2d). Additionally, we investigated the intersect of 
the SF oscillating with a period of 24 ± 3 h for the mouse and for the human samples, oscillations were detected 
using Metacycle59, a specialized R package for the investigation of oscillating behaviour from high-throughput 
data. For the mouse samples we detected an intersect of 9 splicing factors: Hnrnpd, Khdrbs1, Srpk2, Wac, Tardbp, 
Sf3a1, Puf60, Rbm28, Prpf31 (Supp. Fig. S3e). Most of the detected splicing factors (Hnrnpd, Khdrbs1, Tardbp 
and Puf60) are DNA/RNA binding proteins involved in various steps of RNA biogenesis and processing, as well 
as several nuclear processes (such as pre-mRNA splicing)60. Sf3a1, Rbm28 and Prpf31 belong to the spliceosome 
ribonucleoprotein complexes and are thus involved in pre-mRNA splicing61,62. Wac acts as a linker between gene 
transcription and histone H2B monoubiquitination which positively regulates MTOR activity63.
For the HD-MY-Z and U2OS cell lines the intersect results in 24 genes (Supp. Fig. S4) including NONO (U2OS, 
p = 1.178-E05; HD-MY-Z, p = 3.585E-03) and POLR2A (U2OS, p = 2.902E-04; HD-MY-Z, p = 1.637E-02). 
NONO (non-POU domain containing octamer binding) is involved in the regulation of the circadian clock and 
cell cycle via interactions with PER and p16-INK4A (respectively) and acts as a coupling element between both 
processes25,64. POLR2A (RNA polymerase II subunit A) is a DNA-dependent RNA polymerase involved in the 
transcription of DNA to RNA65. Notably, mutations in POLR2A were reported to drive neoplasia in meningioma66 
and play a potential role as a therapy target in various cancer types, including colorectal cancer67. Subsequently, 
we retrieved the sets of oscillating genes and carried out comparisons to determine a possible correlation between 
the number of oscillating genes in the NCRG set and the number of oscillating genes in the SF set, for all data-
sets. Our data shows a spearman correlation of 0.986 between the numbers of oscillating genes from the NCRG 
and the SF from all datasets analysed. In particular, the percentages of oscillating genes in the SF and the NCRG 
follow a similar pattern across tissues and cell lines, as shown in Supplementary Fig. S4, further underlining the 
connection between the NCRG and the SF.
We further investigated in detail the 24 splicing factors for which oscillations are present both in the U2OS 
and the HD-MY-Z cell line. The expression of the 24 splicing factors derived from the HTA 2.0 arrays of our time 
course is shown in Fig. 3 together with the p-values calculated with MetaCycle and summarized from the three 
methods implemented in the package – ARS, JTK and LS. The expression pattern was also used to correlate the 
oscillating splicing factors to the genes for which alternative splicing and oscillation over time are detected (Supp. 
Fig. S5). We show the 9 splicing factors for which oscillations are present in all mouse tissues as Supplementary 
Fig. S3.
Additionally, we performed a correlation analysis for the 24 SF and elements of the clock network. This anal-
ysis points toward a widespread positive correlation between the expression of SF and the expression of the 
core-clock genes with the exception of a negative correlation between RORB/RORC and most other genes from 
the two sets.
The circadian clock affects splicing and induces temporal changes in splicing events. Given 
the seemingly circadian regulation of SF, we set up to investigate whether the interplay between the clock and 
the SF elements had an impact on splicing decisions detectable in HD-MY-Z cell lines. We used a recently 
published time-course data set from our group on the Hodgkin lymphoma cell line HD-MY-Z (ArrayExpress 
E-MTAB-640027) to investigate differential splicing events. This data set comprises of 9 samples per cell line, for 
the cell lines HD-MY-Z and the lymphoblastoid B cell line LCL-HO (RNA collected between 6 h and 30 h after 
synchronization, in 3 h intervals). We took the splicing-sensitive Affymetrix HTA-2.0 arrays as a platform for 
the generation of the time-course expression profiles, and analysed the data with the EventPointer R68 package 
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as described in Materials and Methods. The package supports the inclusion of junction probe information in the 
analysis, which other algorithms focusing on exon arrays lack. We clustered the samples from the individual time 
points with hierarchical clustering to determine similar-behaving time points for the subsequent EventPointer 
comparisons. We excluded the 18 h time point based on the PCA and hierarchical clustering analysis provided 
in Supplementary Fig. S6. The time point was excluded from the subsequent search for splicing events due to 
the large distance of the data from the other time points, which might affect the results in the needed pairwise 
analysis. We grouped the time points in bins containing two time points in chronological order (e.g. 6 h and 9 h 
compared to 12 h and 15 h). The process of binning of time points is widely used to increase the signal to noise 
ratio69–72. This allowed us to produce three comparisons for the subsequent analysis with EventPointer (Fig. 4a).
We obtained a list of genes for which alternative splicing is detected for each comparison (Supp. Tables S6–S8). 
Moreover, we determined the type of event detected, its position, the associated p-value and the delta-PSI (delta 
percent spliced in index) (Comparison 1 – Supp. Table S6, Comparison 2 – Supp. Table S7, Comparison 3 – Supp. 
Table S8). The percent spliced-in index (PSI) denotes the ratio between probe sets including or excluding the 
Figure 3. The expression of the 24 splicing factors detected to oscillate in human samples shows marked 
changes over time. We detected the oscillations of the genes through high-throughput analysis with MetaCycle. 
p-values given are for periods between 21 and 27 hours.
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exons, and thus provides information concerning the degree of variation in splicing68. We filtered the resulting 
data for events with p < 0.01 and absolute delta-PSI > 0.1, to identify significant differential splicing events across 
the time points. The PSI filtering identifies the changes in alternative splicing that shift the balance of isoforms and 
hence have the highest potential for biological impact. The delta-PSI values showing this behaviour after p-value 
filtering are depicted in Supplementary Fig. S7. In comparison 1, we detected 249 (Supp. Table S6) unique genes 
to be alternatively spliced after filtering. In comparison 2, 261 (Supp. Table S7) unique genes are alternatively 
spliced after filtering, and in comparison 3 we found 235 unique genes (Supp. Table S8) alternatively spliced. We 
further investigated this gene set by creating a comparative analysis for Reactome terms enriched in the different 
time points (Fig. 4b, Supp. Table S10). The gene set in comparison 1 shows an association to the cell cycle (G2/M 
Transition, p = 5.271E-03, Mitotic G1-G1/S phases, p = 4.430E-03). The gene sets in comparison 2 and 3 differ 
mainly in the strong signal of the apoptotic execution phase present in comparison 2. This enrichment in compar-
ison 2 (p = 6.790E-05) is caused by the genes ADD1 (adducin 1), SPTAN1 (spectrin alpha, non-erythrocytic 1), 
ACIN1 (apoptotic chromatin condensation inducer 1) and GSN (gelsolin), all targets of the caspase 3 and ele-
ments of the apoptotic execution pathway. Both comparisons 2 and 3 contain enrichments of terms related to 
mRNA processing and splicing (Processing of Capped Intron-Containing Pre-mRNA, p = 3.373E-06), highlight-
ing the potential circadian regulation of such processes.
Following the application of the previously described filtering, we obtained 623 unique genes after merging 
the data from comparison 1, comparison 2 and comparison 3. These genes represent the ones that passed filtering 
and for which an alternative splicing event or events was detected in at least one comparison for the HD-MY-Z 
cell line. Additionally, we performed a correlation analysis between the expressions of oscillating SFs and AS 
genes in the HD-MY-Z cell lines (Supp. Fig. S5), we observe a strong and widespread positive correlation between 
Figure 4. Numerous alternative splicing events were detected in the time-course data for the HD-MY-Z cell 
line. (a) Experimental design for the grouping and subsequent analysis of the time-course microarray data 
with the EventPointer R package. The time points were grouped in four sets that resulted in three EventPointer 
comparisons. The data obtained with EventPointer was additionally filtered for p < 0.01 and absolute delta-
PSI > 0.1. The selected genes were visualized at the probe set level with the GenomeGraphs package. (b) 
Enrichment analysis for Reactome pathways for the genes detected to be alternatively spliced in the three 
comparisons. The gene ratio denotes the ratio between the number of the genes associated with the term and the 
total number of genes associated with the term in the pathway.
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the two data sets, indicating an important connection between the SFs and the AS genes. Our results identified a 
set of alternatively spliced genes in HD-MY-Z cells, which are involved in key cellular pathways that affect apop-
tosis and the cell cycle and consequently are likely to play a role in cell proliferation.
circadian regulation of splicing factors leads to switches in alternative splicing of target genes 
in HL cell lines. Furthermore, we searched for a temporal pattern in the detected splicing events. To investi-
gate the existence of potential temporal changes in the spliced genes, possibly in a rhythmic manner, we extracted 
the genes that undergo alternative splicing events in each of the three comparisons for the HD-MY-Z cell line at 
the same genomic coordinates according to the annotation and with a p-value cutoff of 0.01 and absolute delta-PSI 
value of at least 0.1 in at least one comparison, as described in the previous section. Our analysis resulted in a list 
of 42 alternatively spliced genes for which alternative splicing events are present in all comparisons with p < 0.01 
(Supp. Table S9) and show the highest variance in delta PSI in the three comparisons. The variance analysis was 
performed to focus on genes with potential changes in splicing over time. Indeed, out of the 42 genes 21 show an 
oscillatory behaviour of their respective gene expression as detected by MetaCycle. We ordered the genes varying 
in each comparison by the variance in their delta-PSI values, which reflects strong changes in splicing between the 
comparisons. Several genes within this set, such as DPYD (p = 3.17E-04, Supp. Table S8) and POP4 (p = 4.69E-05, 
Supp. Table S8), show temporal changes between the expressions of one or more exons in the HD-MY-Z cell line. 
EventPointer classifies this event as a “Cassete Exon”, a case of exon skipping. Both DPYD and POP4, involved 
in drug metabolism and RNA processing/transport, respectively, oscillate in a circadian manner as detected in 
our analysis with MetaCycle. Other interesting candidates are MAGOH (p = 3.90E-06, Supp. Table S8) involved 
in RNA transport, and SS18 (Synovial Sarcoma Translocation, Chromosome 18), p = 3.75E-07 (Comparison 3, 
Cassette Exon type splicing event), which is related to synovial sarcoma and its splice variant lacking exon 8 was 
shown to increase the malignant potential in synovial sarcoma73 (Supp. Table S8). A further cancer-related gene 
with rhythmic AS, based on our results, is VIPR1 (Vasoactive Intestinal Peptide Receptor 1 gene, p = 9.71E-05, 
Supp. Table S8). A recent study comprehensively investigated the cytoprotective effects of the small neuropeptide 
VIP and its receptor (VIPR1) in cancer stem cells and identified an antiapoptotic function of the VIP receptor in 
these cancer cells74.
To further investigate the putative connection between the circadian clock and rhythmically expressed SFs 
and AS genes, we generated a shRNA knockdown cell line of the core-clock gene Bmal1 (HD-MY-Z-shBmal1) 
and evaluated the knockdown efficiency using a bioluminescence assay for Bmal1 promoter activity recordings 
(Fig. 5a,b and Supp. Fig. S12). As seen from our data, the expression pattern of Bmal1 promoter activity is reduced 
in the shBmal1 cell line as compared to the control (HD-MY-Z-ctrl, transduced with an empty vector). Next, 
we generated a time-course data set (9h-30h, in 3 h intervals) for both the control and shBmal1 cell lines and 
measured gene expression levels for two SFs (SRSF5 and HNRNPAB, Fig. 5c) and three AS genes (IRF4, DPYD 
and POP4, Fig. 5d) by RT-PCR. From the harmonic regression analysis, we observed that all genes analysed show 
rhythmic expression (p < 0.05), with phases similar to the ones identified via our bioinformatic approach (Figs 3 
and 5e). The best fitting curves are depicted in Fig. 5c,d and their circadian parameters (period, p-value, ampli-
tude, acrophase, and acrophase shift between control and shBmal1 condition) are provided in Supplementary 
Table S11 for variable periods and Supplementary Table S12 for 24h-periods. Furthermore, we identified different 
oscillation phenotypes in the shBmal1 cell line as compared to the control cell line, reinforcing our results on a 
possible link between the circadian clock and rhythmically expressed SFs and AS genes (Fig. 5c,d). We observed 
that the perturbation in the clock gene Bmal1 affected the expression of SF and alternatively spliced genes. In the 
shBmal1 condition, the phase of POP4, DPYD, and IRF4 genes occurred 0.12 h, 0.51 h, and 2.17 h before their 
corresponding peaks in the control condition, respectively (Supp. Table S11). As expected, the differences in the 
oscillatory expression phenotype between both conditions were more pronounced for the SF genes. In shBmal1 
condition, the HNRNPAB and SRSF5 had a phase of expression 2.99 h and 3.30 h before their corresponding 
expression peaks in the control condition, respectively (Supp. Table S11). These results point to a potentially 
closer and more direct relation between SF and clock genes, as compared to the clock genes and the alternatively 
spliced candidate genes.
While investigating the previously mentioned list of 42 genes (alternatively spliced genes for which alterna-
tive splicing events are present in all comparisons, Supp. Table S9) that undergo alternative splicing and hence 
show high delta-PSI variance in the HD-MY-Z cell line, we detected a strong signal for IRF4 (p = 3.29E-05, 
Supp. Table S8) from an event classified as an “alternative last exon”. A strong difference between the sig-
nals from the 6 h and 9 h time points as compared to the remaining time points is visible (Fig. 5f ). IRF4 
shows oscillations in expression (p = 7.90E-05, Fig. 5e), and the alternative splicing signal for IRF4 is present 
in each comparison. IRF4 has five known isoforms, for which however only two lead to known proteins, the 
ENST00000380956 and the ENST00000493114. The short isoform, ENST00000493114, does not include the last 
exon (ENSE00001957207) of the gene, which can account for the signal detected. This isoform also differs from 
the canonical ENST00000380956 form by not fully including the interferon regulatory factor 3 domain and the 
SMAD/FHA domain, otherwise present (Fig. S10). Most importantly, this isoform undergoes nonsense-mediated 
decay (NMD). Interestingly, the IRF4 gene has a high expression in Hodgkin Lymphoma (observed in stage IV 
HL cell lines), as well as an anti-proliferative and pro-apoptotic effects in several HL cell lines upon silencing75,76. 
To verify if the observed splicing behaviour differs from a non-cancer cell line, we analysed a 24 h time-course 
data set for the LCL-HO cell line (B lymphoblastoid cell line). In this cell line the difference in IRF4 splicing was 
not observed (Supp. Fig. S8). Additionally, the genes CABYR (calcium binding tyrosine phosphorylation regu-
lated), ARHGEF39 (rho guanine nucleotide exchange factor 39), NUDT16 (nucleoside diphosphate-linked moi-
ety X motif 16), SEPT10 (septin 10), CDC45 (cell division cycle 45) and TUBA3C (tubulin alpha 3c), for which we 
also detected significant changes in the splicing over time for the HD-MY-Z cell line are shown in Supplementary 
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Fig. S9. Interestingly, while some of the time-specific alternative splicing events are present in both cell lines with 
similar patterns in the expression of the probesets, others show strong differences such as large changes of expres-
sion over time that only affect a part of the probes of a gene and hence point at alternative splicing changes over 
Figure 5. The knockdown of the core-clock gene Bmal1 affects the expression of SF and alternatively spliced 
genes. (a) Bioluminescence measurements of Bmal1 promoter activity in HD-MY-Z control (ctrl) cells and 
HD-MY-Z-shBmal1 cell lines. Bioluminescence was measured for approximately five consecutive days. 
Shown is one representative replicate and the mean value for the period (T) evaluated with Chronostar, 
ND = non-defined. Mean ± SEM, n = 3. (b) Gene expression analysis of Bmal1 after shBmal1 compared to 
the corresponding control gene. Mean ± SEM, n = 3. Knockdown efficiency in HD-MY-Z-shBmal1 cells, 
0.370 ± 0.009 (63%), **p < 0.01. (c) Harmonic regression of RT-PCR data for splicing genes (HNRNPAB, 
SRSF5) and for (d) alternatively spliced genes (POP4, DPYD, and IRF4) in the control (black) and shBmal1 
(green) conditions for the cell line HD-MY-Z. The solid lines show the best fitting harmonic regression and the 
dashed vertical lines show the phase of the oscillation (p < 0.05, mean ± SEM, n = 3; n = 2, DPYD time point 
27 h). (e) The expression levels of IRF4, DPYD and POP4 shows rhythmic behaviour (analysis with MetaCycle). 
(f) Visualization of the expression data from all nine time-course arrays for the HD-MY-Z cell line for IRF4. The 
structure of the gene and the corresponding known isoforms are displayed. IRF4 was detected to be alternatively 
spliced with the event type - alternative last exon. In this case, two time points (6 h, 9 h) present a significantly 
different isoform balance then the remaining time points. Of the known transcripts, only the longer transcripts 
ENST00000380956 and ENST00000493114, which seem to be the ones affected by the change in balance, are 
known to result in protein products.
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time that differ between the cell lines. This is particularly visible for CABYR, the splicing of this gene varies over 
time for the LCL-HO and HD-MY-Z cell lines. Different splice variants of CABYR have been identified so far, 
which show different calcium-binding capacities77 and the differential expression of these variants was shown to 
exhibit aberrant expression in brain tumours and brain cancerous cell lines78.
To explore the role of the circadian clock as a regulator of the observed alternative splicing events, we further 
analysed the interactions between the identified alternatively spliced genes, the NCRG and the SF genes sets. For 
this, we expanded the previously established NCRG by including the SF and the 623 alternatively spliced genes 
identified by our pipeline (unique genes in all comparisons) in the HD-MY-Z cell line, regardless of their circa-
dian behaviour. We also included all interactions retrieved from the IntAct database (Fig. 6a). This new network 
is based on the previous network of the NCRG and splicing factors (Supp. Fig. S2) and contains 299 direct inter-
actions between the alternatively spliced genes and SF, 222 direct interactions between the alternatively spliced 
Figure 6. The SF and the NCRG interact with the alternatively spliced genes and show similar rhythms in the 
HD-MY-Z cell line. (a) The previous NCRG interacting with the SF was extended to include the alternatively 
spliced genes (ASG) for the HD-MY-Z cell line. This new network shows 299 direct interactions between the 
alternatively spliced genes and SF and another 222 direct interactions between the alternatively spliced genes 
and the NCRG. (b) Correlation analysis of 21 of the 42 genes for which changes in alternative splicing were 
detected in each comparison of the HD-MY-Z time course and the CLOCK gene. The expression of the 21 
genes oscillates with approximately circadian rhythm according to analysis performed with MetaCycle. The 
expression of multiple genes such as POP4 correlates with the expression of CLOCK. Binding sites for CLOCK 
were detected in the promoter regions of the splicing factors (p = 2.60E-25, Fig. 2b). The expression of multiple 
genes that undergo splicing over time and oscillate with approximately circadian rhythm is correlated with 
the expression of CLOCK: VIPR1 (correlation. −0.86), DPYD (0.76), POP4 (0.68), STRN3 (0.90). Red colour 
denotes negative correlation and blue colour denotes positive correlation with the size and intensity of the 
circles reflecting the difference of the value from 0. (c) Network of the splicing factors and circadian regulated 
genes connected to the alternatively spliced genes. Expression data from the time-course HTA 2.0 microarrays 
was added to the network. The new network is reduced to the genes for which expression data could be 
obtained from the arrays and contains a total of 290 nodes and 409 edges. Of those, 62 nodes are part of the 
NCRG, 76 nodes are part of the SF, 132 nodes are part of the spliced genes and 16 nodes belong to both the SF 
and the NCRG underlining their close interaction. The expression values shown are for the 6 h time point and 
normalized in the range (−1, 1) with red representing high expression and green representing low expression. 
(d) Identical network structure with the expression data for the 18 h time point and normalized in the range 
(−1, 1) with red representing high expression and green representing low expression. The expression peaks 
at this time point as also visible in the heatmaps in Fig. 2 (e) Identical network structure with the expression 
data for the 30 h time point and normalized in the range (−1,1) with red representing high expression and 
green representing low expression. Following the peak at 18 h the 30 h time point shows a strong reduction in 
expression.
1 1Scientific RepoRtS |         (2019) 9:11062  | https://doi.org/10.1038/s41598-019-47343-w
www.nature.com/scientificreportswww.nature.com/scientificreports/
genes and the NCRG as well as 186 connections between the splicing factors and the NCRG. A detailed view of 
the network is provided in Supplementary Fig. S11. To further explore the network, we integrated the expression 
data from the time-course arrays for the HD-MY-Z cell line. The three groups showed similar oscillation pattern 
and an overall change towards higher expression levels at 18 h (Fig. 6c–e). Altogether, our data point towards a 
correlation between the circadian clock phenotype and the expression patterns of SF in HD-MY-Z cells. This is 
further shown by the correlation between the expression of the gene CLOCK with the expression of several of 
the genes undergoing changes in splicing over time (Fig. 6b). We found enriched binding sites for the CLOCK 
gene in the promoter regions of the SF (p = 2.60e-25), if the splicing factors are putatively regulated by the clock 
their subsequent output in AS is likely to be regulated as well. We investigated this hypothesis on the expression 
of the 21 genes previously detected to undergo changes in splicing in each comparison and having oscillations 
with a period of 24 ± 3 h (p < 0.05 as calculated by MetaCycle). The previously detected genes with splicing events 
correlate (Pearson correlation) with the expression of CLOCK – VIPR1 (correlation, −0.86), DPYD (correlation, 
0.76), POP4 (correlation, 0.68), STRN3 (correlation, 0.90). This interplay between the clock network and the SFs 
results in temporal changes of AS in these cells and suggests a regulatory role of the clock as a possible effector of 
cancer phenotype via the splicing machinery.
Discussion
In this study, we explored the role of the circadian clock network in influencing alternative splicing in HD-MY-Z 
cells with a bioinformatics approach using time-course microarray data recently published by our group27. We 
built upon previously published data, which reported stage-specific patterns of AS and SF for HL cells from differ-
ent tumour stages11. These patterns were successfully used to classify the stage of each tumour and to distinguish 
between a non-tumour cell line and cancer11. To explore the role of the circadian clock as an important and medi-
atory partner in this interplay, we first determined the number of oscillating genes in the NCRG and SF groups 
in several time course array data sets for mammalian tissues and cell lines, and compared their expression and 
oscillatory patterns (Supp. Figs S3 and S4). We observed a correlation between the number of oscillating genes 
in NCRG and SF with similar rhythmic expression patterns across various mouse tissues, and in human cancer 
cell lines (U2OS and HD-MY-Z). It is important to mention, that the oscillation profile of gene expression within 
different cancer cell lines, as well as compared to a non-cancer cell line (LCL-HO) is different. Previous studies 
have shown, that various cancer cell lines exhibit a range of diverse oscillation phenotypes28. In a recent study 
by our group, we examined the oscillation pattern of gene expression in the HL cell line HD-MY-Z compared to 
a lymphoblastoid B cell line LCL-HO (as a non-cancer cell model) and found a strong connection between the 
oscillating genes and cancer related pathways, in the HD-MY-Z cell line27. Thus, in this particular cellular model, 
a properly functional circadian clock in the HD-MY-Z cell line might be relevant for the malignant phenotype 
of these cancer cells. As seen from the time-course array data for several mouse tissues and human cell lines 
(summarized in Fig. 2 and Supp. Fig. S3), these expression patterns and correlations are tissue-specific, pointing 
to the distinct and specific circadian regulation of physiological and cellular processes in each tissue and cell type. 
Interestingly, we showed that several core-clock and clock-related genes (AHR, ATF2, CLOCK, SMAD4, TEF, 
IRF7, SP1, ARNTL, ARNT2 and EGR1) recognize the promotor region of SF and act as TFs directly regulating the 
expression of the elements of the splicing machinery (Fig. 2a,b).
Previous studies, including work from our group indicate that the circadian clock plays a key role in regulating 
metabolism26, the cell cycle and cell proliferation25. Given the interplay between the clock and SF highlighted by 
our data, we hypothesise that one possible additional way via which the clock affects cellular processes, including 
the cell cycle, is by the temporal regulation of splicing events of the effector genes. Indeed, the observed temporal 
change in the expression of SFs correlates with changes in alternative splicing, which occur in the cancer cell 
line and that influence apoptosis and proliferation. Using our bioinformatics pipeline applied to multiple com-
parisons of time points, we investigated the impact of the differential oscillations of SFs in alternative splicing, 
and identified several alternatively spliced genes in the HD-MY-Z cell line with rhythmic patterns of isoform 
expression. One example is the SS18 gene involved in transcriptional dysregulation in cancer which is associated 
with synovial sarcoma79. Another gene with rhythmic alternative splicing is MAGOH involved in RNA transport, 
splicing and nonsense-mediated decay. We further identified several genes involved in metabolism, among them 
the DPYD, involved in drug metabolism. DPYD is associated with dihydropyrimidine dehydrogenase deficiency, 
leading to increased risk of toxicity in cancer patients receiving chemotherapy80. Effectors of the cell cycle are 
differentially spliced during a 24 h period in our data sets. In particular, VIPR1, which is involved in the antia-
poptotic pathway in cancer cells and acts as proliferation regulator74. These results highlight the significance of 
a failure in the temporal control of alternative splicing which influences major cellular pathways with possible 
subsequent effects in cancer onset or progression. One of the genes that we identified to be alternatively spliced in 
a timely manner in HD-MY-Z was IRF4 (Fig. 5f). This gene is a member of the IRF family of transcription factors 
expressed in cells of the immune system. IRF4 acts as a key regulator of several steps in lymphoid and myeloid cell 
differentiation, and is associated with many lymphoid malignancies. Previous studies showed that IRF4 is highly 
expressed in HL cells and its silencing inhibits HL cell proliferation and induces apoptosis76. Our data suggest that 
the rhythmic alternative splicing of IRF4 may contribute to its over expression in HD-MY-Z, which in turn may 
regulate the progression stage of tumorigenesis in these cells. Since this rhythmic alternative splicing is directly 
correlated with the clock, we hypothesise that changes in clock expression are correlated with the AS pattern 
of IRF4, hence affecting the cancer phenotype. Our hypothesis is further supported through the RT-PCR data, 
where we identified oscillations in the expression of the SFs HNRNPAB and SRSF5, as well as in the alternatively 
spliced candidate genes IRF4, POP4 and DPYD in the control condition and a different oscillatory phenotype 
for the same genes in the Bmal1 knockdown cell line (Fig. 5c,d). The fits obtained from the harmonic regres-
sion analysis are statistically significant (p-value < 0.05), and the circadian parameters derived from the analysis 
(e.g.: acrophase, period, and amplitude) differ between control and shBmal1 condition (Suppl. Table S11, Suppl. 
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Table 12). Yet, to fully evaluate these results and find possible mechanistic explanations at both molecular and cel-
lular levels, further experimental studies need to be performed in future follow up studies also at the protein level. 
Of note, it was previously reported that though no, or weak, rhythmic gene expression at the transcript level was 
detectable, the protein level showed robust rhythmic oscillation. Gotoh and colleagues showed strong rhythmic 
protein levels of p53 although there was no oscillation detectable at the mRNA level81.
Altogether, our data points toward an additional role of the circadian clock in controlling RNA processing via 
the temporal regulation of the splicing machinery. Given the impact of this regulation in alternative splicing and 
the known relevance of the latest in cancer progression, our data highlights a layer of temporal transcriptional 
complexity likely to have an impact in tumorigenesis.
Materials and Methods
cell culture. HD-MY-Z (DSMZ – #ACC 346) cells were maintained in RPMI 1640 (Gibco) supplemented 
with 1% penicillin-streptomycin (Gibco) and 10% foetal bovine serum (Gibco). Stable-transduced cells were 
selected and maintained in medium containing 100 μg/mL hygromicin B (Gibco) for the Bmal1:luc hygromicin 
(BLH) and 10 μg/mL of puromycin for the shRNA KD of the clock gene BMAL1. For live-cell bioluminescence 
recording (evaluation/analysis/monitoring), cells were maintained in phenol red-free RPMI 1640 (Gibco) con-
taining 10% foetal bovine serum, 1% penicillin-streptomycin and 0.1 mM D-Luciferin (PJK). All cells were incu-
bated at 37 °C with 5% CO2 atmosphere.
Lentivirus production. Lentiviral elements containing a BMAL1-promoter-driven luciferase (BLH) 
and an empty vector (TRC Lentiviral pLKO.1 Empty Vector Control Dharmacon Inc., Lafayette, CO) or the 
shRNA KD (TRC Lentiviral Human ARNTL shRNA - Clone ID: TRCN0000019097) were used in the pres-
ent work. HEK293T (human, kidney, ATCC Number: CRL-11268) cells were seeded in 175 cm2 culture flasks 
and co-transfected with 12.5 µg packaging plasmid psPAX, 7.5 µg envelope plasmid pMD2G and 17.5 µg BLH or 
shRNA KD expression plasmid using the CalPhos mammalian transfection kit (Clontech) according to the man-
ufacturer’s instruction. To harvest the lentiviral particles, the supernatant was centrifuged at 4100 × g for 15 min 
to remove cell debris and passed through a 45 µm filter. Lentivirus were stored at −80 °C.
transduction with lentiviral vectors. 1 × 106 cells were seeded in a 6-well plate with 1 mL of RPMI1640, 
10% foetal bovine serum, 1% penicillin-streptomycin and 4 µg/mL Polybrene (Sigma). 1 mL of supernatant of the 
corresponding lentivirus were added to each well and plates were centrifuged for 90 min at 34 °C at 1000 g. The 
supernatant was discarded after 4 hours incubation at 37 °C with 5% CO2 and 2 mL of fresh medium was added. 
Two days after, the medium was replaced by selection medium (supplemented with hygromicin S or puromycin 
(according to the lentivirus construct used)) and incubated at 37 °C with 5% CO2 atmosphere. Cells were main-
tained in selection medium for at least two weeks. For the shRNA KD, the KD efficiency was determined by gene 
expression analysis.
Synchronization and measurement of circadian rhythms. For bioluminescence measurement, 
0.5–1 × 106 cells were washed once with 1 × PBS, plated in 35 mm dishes and synchronized by adding fresh 
phenol-red-free RPMI 1640 medium supplemented with 10% foetal bovine serum, 1% penicillin-streptomycin 
and 0.1 mM D-Luciferin. Bmal1-promoter-(BLH)-reporter activity was measured, using the LumiCycle instru-
ment (Actimetrics). After bioluminescence recording for 5–7 days, phase, period and amplitude were analysed 
with the ChronoStar82 analysis software V3.0 using 24 h running average de-trended method and fitting cosines 
curves were calculated as output.
RnA isolation and cDnA synthesis. Cells were seeded in 35 mm dishes with a density of 5 × 105 cells/
dish and synchronized by fresh medium addition. Cells were collected every three hours, in triplicates and the 
pellets were stored at −80 °C. Total RNA was isolated using the RNeasy extraction kit (Qiagen), including DNase 
digestion, according to the manufacturer’s instructions. Cells were lysed with 350 µl RLT buffer and the lysate was 
homogenized. Total RNA concentration was determined using NanoDrop® ND-1000 UV-Vis Spectrophotometer 
and stored at −80 °C °C. 1 µg of total RNA was reverse-transcribed to cDNA with M-MLV reverse transcriptase 
(Invitrogen), random hexamers (Eurofins MWG Operon) and dNTPs Mix (Thermo Fisher).
Quantitative real-time pcR. For gene expression quantification, we used SYBR-Green (Bio-Rad 
Laboratories, Hercules, CA) based real-time PCR in 96-well plates and the human commercial primers from 
QuantiTect primer assays (Qiagen) for GAPDH and BMAL1. For POP4, DPYD, IRF4, HNRNPAB, and SRSF5 
genes following primers were used: POP4 (Forward: 5′CGG TCC GAG AAT GAA GAG TGT; Reverse: 5′GGC 
TGG ACA TCG GAG TCA TT); DPYD (Forward: 5′ACT CTG TGT TCC ACT TCG GC; Reverse: 5′CAG GCA 
TCT CAT TGC TTC TCG); IRF4 (Forward: 5′GTG AAA ATG GTT GCC AGG TGA; Reverse: 5′AGG CTT 
CGG CAG ACC TTA TG); HNRNPAB (Forward: 5′TGT CAG TGG AAG CAA GTG TGA; Reverse: 5′CTG GTT 
CCA GTA GTT GCC GT); SRSF5 (Forward: 5′CAG CAA AAG GCA CAG TAG GT; Reverse: 5′CCG GCT GTA 
AGA TTT GCG AC). The reaction was performed in a real-time PCR Detection System (Bio-Rad). Each sample 
was measured in triplicates and the CT values were determined by using the regression method. The expression 
levels were normalized to those of GAPDH (ΔCT) and calibrated to the mean expression value of each gene 
(time-course analysis) or in relation to the control (ΔΔCT). The relative quantification was performed using 
the 2−ΔΔCT method83.
Western blotting. For protein isolation, cells were gently detached from the dish, sedimented by low-speed 
centrifugation and resuspended in lysis buffer. Aliquots containing 30 µg of proteins from each cell lysate were 
used for SDS polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (GE Healthcare) 
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using the Trans-Blot Turbo Transfer System (Bio-Rad). Membranes were probed with the following primary anti-
bodies: BMAL1 (1:2000; Abcam ab93806) and GAPDH (1:2500; Abcam ab9485). After incubation with corre-
sponding suited horseradish peroxidase-conjugated secondary antibody (1:2000; Abcam ab205718), signals were 
developed using the enhanced chemiluminescence kit (ECL™ Prime Western Blotting System, GE Healthcare), 
acquired by ChemiDoc Imaging System XRS + (Bio-Rad) and analysed for densitometry with the ImageJ software.
cancer cell lines and sampling. HD-MY-Z (DSMZ – #ACC 346: nodular sclerosing Hodgkin lymphoma 
stage IIIb refractory to therapy) and LCL-HO (DSMZ – #ACC 185: B lymphoblastoid cells) this data set was 
recently published in Abreu et al.27, cells were synchronized by medium change and samples were collected 
every three hours between ZT06h and ZT30h. One array per time point was hybridized at the LFGC (Labor für 
funktionelle Genomforschung, Charité - Universitätsmedizin Berlin). The microarray dataset is deposited in the 
ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-640027.
enrichment analysis. Enrichment analysis was performed with the clusterProfiler84 and ReactomePA85 R 
packages using Reactome Pathways. The enrichment of Reactome pathways was performed with a p-value cutoff 
of 0.05, q-value cutoff of 0.2, “universe” selection for background genes and a Bonferoni-Hochberg correction for 
multiple testing. ClusterProfiler analysis was performed with a p-value cut-off of 0.05 and no correction for mul-
tiple testing. Enrichment analysis for transcription factor binding sites was performed with the MEME suite’s86 
AME tool and the HOCOMOCO47 database v10.
network creation and random network analysis. The protein-protein interaction networks were 
created with data from the IntAct database. Cytoscape 3.687 was used for visualization and network clustering 
with the clusterMaker app. For the generation of random networks we used the 2015 IntAct snapshot present in 
the iRefIndex36 database and the iRefR R88 package. Network clustering was performed with the clusterMaker89 
Cytoscape app.
Array processing and detection of oscillating genes. The time-course data from the Affymetrix HTA-
2.0 arrays were analysed with R and the oligo package, the normalization was performed with the RMA algorithm 
on the TCO level for oscillating gene analysis. On TCO level the arrays were annotated with the hta20transcript-
cluster.db package from Bioconductor90. The computational analysis for oscillating genes was performed with 
the MetaCycle59 R package with all supported methods (ARS, JTK, LS) for the period range of 21 h to 27 h. The 
reason for selecting this period range is based on a recent published study by our group investigating the oscilla-
tion of gene expression in the mentioned cell lines27. Only oscillating genes with a combined p-value lower than 
0.05 were used for the further analysis. The microarray dataset was deposited in the ArrayExpress database at 
EMBL-EBI (www.ebi.ac.uk/arrayexpress) under the accession number E-MTAB-6400 and will be release d upon 
publication. The mouse arrays were retrieved from circadb (circadb.hogeneschlab.org)91.
Detection and visualization of splicing events. For the detection of splicing events the arrays were 
pre-processed with the aroma.affymetrix R package and analysed with the EventPointer R68 package with the 
annotation cdf suggested by the package author. Each two time points were taken as replicates and three pairwise 
comparisons were so performed for each cell line. The 18 h time point was excluded based on clustering data 
and PCA given in Supplementary Fig. S5. The detected candidate genes were visualized with GenomeGraphs92 
R package from data on probe set level passed through the RMA algorithm. Genomic locations of the probe sets 
were retrieved from the Affymetrix annotation and data on the isoforms and the gene structure was retrieved 
from ensembl biomart grch37. Probe set level annotation was provided by the hta20probeset.db package in 
Bioconductor90.
Statistical analysis. The experiments were carried out with three biological replicates for each condition 
(for time point 27 h of DPYD, n = 2). All results are represented as mean ± SEM. Statistical analysis was per-
formed using two-tailed unpaired t-test. A p-value < 0.05 was considered as statistical significant (*p < 0.05; 
**p < 0.01; ***p < 0.001). The rhythmicity of the genes HNRNPAB, SRSF5, POP4, DPYD, and IRF4 (control and 
shBmal1 condition) was tested by fitting a linear sine-cosine function to the time-course data (ΔΔCT normalised 
to the mean) using the R package HarmonicRegression93. Eight time points (9 h–30 h) were included in the anal-
ysis. The harmonic regression procedure fits the model y(t) = m + acos(ωt) + bsin(ωt) to the time-course data to 
estimate absolute amplitudes (A = √(a2 + b2)) and phases (φ = atan2(b,a)) for a given period93. Periods from 14 h 
to 27 h in increments of 0.1 h were tested. The circadian parameters (p-value, amplitude, acrophase), as well as the 
acrophase shift between control and shBmal1 condition were determined. The significance was calculated with an 
F-test of the model fit and bounded by p < 0.05. The best fitting curve (lowest p-value) was used for visualization.
Data access. The microarray data For the HD-MY-Z and LCL-HO cell lines from this study is depos-
ited in the ArrayExpress database at EMBL-EBI (www.ebi.ac.uk/arrayexpress) under the accession number 
E-MTAB-6400. The mouse arrays were retrieved from circadb (circadb.hogeneschlab.org)91 under the GEO 
identifiers: GSE11923 (Mouse Liver), GSE25585 (Mouse Macrophages), GSE11922 (NIH 3T3) or directly from 
circadb (Mouse Pituitary58). The additional U2OS arrays can be found under the GEO identifier GSE13949.
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